Rocket


Overview
Financials
News + Filings

 
 

Menlo Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-16Dec-31-15
Revenues11.32.9
            Revenue growth285.3% 
Cost of goods sold15.04.6
Gross profit-3.8-1.7
            Gross margin-33.3%-57.8%
General and administrative3.81.7
EBIT-14.3-4.6
            EBIT margin-127.3%-157.8%
Pre-tax income0.00.0
Income taxes0.00.0
Net income0.00.0
            Net margin0.0%0.0%
 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2017 | Contact Us | Terms of Use | Privacy